Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.

Source:http://linkedlifedata.com/resource/pubmed/id/7493334

Cancer Res. 1995 Dec 1 55 23 Suppl 5721s-5725s

Download in:

View as

General Info

PMID
7493334